Genmab
GMAB
GMAB
213 hedge funds and large institutions have $1.59B invested in Genmab in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 71 increasing their positions, 82 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.89% less ownership
Funds ownership: 66.04% → 63.15% (-2.9%)
12% less call options, than puts
Call options by funds: $581K | Put options by funds: $661K
13% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 82
Holders
213
Holding in Top 10
2
Calls
$581K
Puts
$661K
Top Buyers
| 1 | +$54M | |
| 2 | +$5.13M | |
| 3 | +$4.28M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.27M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$4.24M |
Top Sellers
| 1 | -$38.3M | |
| 2 | -$27M | |
| 3 | -$23.6M | |
| 4 |
Millennium Management
New York
|
-$11.4M |
| 5 |
Renaissance Technologies
New York
|
-$8M |